This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Implantable Collamer Lens Market

Market Insights on Implantable Collamer Lens covering sales outlook, demand forecast & up-to-date key trends

Implantable Collamer Lens Market by Indication, End User & Region - Forecast 2022 – 2032

Implantable Collamer Lens Market Outlook (2022-2032)

[250 Pages Report] The global implantable collamer lens market is expected to reach a valuation of US$ 244.8 Mn in 2022. Demand is projected to increase at a CAGR of 13.1% over the forecast period, with the market size reaching US$ 838.2 Mn by 2032.

According to the recent study by Future Market Insights (FMI), the myopia disease indication is leading the market with a share of around 78.2% in the year 2021.

Attributes

Key Insights

Implantable Collamer Lens Market Base Year Value (2021)

US$ 212.9 Mn

Estimated Market Size (2022)

US$ 244.8 Mn

Projected Market Valuation (2032)

US$ 838.2 Mn

Value-based CAGR (2022-2032)

13.1%

Key Market Players

STAAR SURGICAL

Implantable collamer lens are an example of a posterior chamber phakic intraocular lens (pIOL). When corneal refractive surgery is not an option with substantial levels of refractive error, pIOL are employed. Faster healing and reversibility are benefits of implantable collamer lens over corneal refractive surgery, because they are less apparent from the outside and pose a lower risk of endothelial cell loss (ECL) due to being positioned farther from the cornea than anterior chamber (AC).

Customize this Report

Let us know your requirement to get
100% FREE customization

2017-2021 Implantable Collamer Lens Market Historic Outlook Vs 2022-2032 Forecast

Sales in the implantable collamer lens represented 16.0% of the overall US$ 4.9 Bn worth global intraocular lenses market in 2021.

There are few surgical alternatives available for correcting refractive defect in patients with extreme myopic astigmatism. Patients with low to moderate myopic astigmatism are preferred candidates for corneal refractive procedures including photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK), as these techniques are constrained by corneal thickness and keratometry for safe ablation.

In individuals with severe myopic astigmatism, over-ablation can lead to higher order aberrations and other postoperative problems such corneal ectasia. By dividing the significant refractive correction between a corneal laser ablation and an implantable collamer lens, Bioptics attempts to overcome this constraint.

The U.S. FDA Post Approval Study (PAS) of the Implantable Collamer Lens for Myopia (MICL) has produced long-term data which has added to the current understanding of safety in regard to the occurrence of endothelial cell loss, cataract, and elevated intraocular pressure.

The most popular treatment for correcting refractive defects uses an excimer laser to reshape the cornea, and is known as laser-assisted in situ keratomileusis (LASIK). However, there are restrictions when used to fix high refractive cylinder. The results of LASIK for myopic astigmatism may be affected by the presence of ocular residual astigmatism, discrepancy between refractive and topographic astigmatism axis, and the influence of internal optical astigmatism.

Implantable Collamer Lens Market Download Report Brochure

What are the Key Opportunities for the Implantable Collamer Lens Manufacturers?

Currently, using small incision lenticule extraction (SMILE) to treat low to moderate myopia is widely accepted. However, SMILE has its own intrinsic limitations, including thick ablation depths, limited ablation zones, and greater aberrations. SMILE could also raise the risk of haze, corneal ectasia, myopic regression, and dry eye.

The postoperative spherical equivalent error (SER) is observed to be predictable and consistent, making implantable collamer lens (ICL) implantation a promising technique for high myopia correction.

By including patients with thin corneas and even keratoconus, ICL implantation broadened the target population. Studies that compared ICL implantation with SMILE for the treatment of high myopia reached conflicting conclusions. However, widely accepted results of ICL implantation have reportedly outperformed SMILE in terms of higher-order aberrations (HOAs), refractive correctness, and uncorrected distance visual acuity.

Backed by these factors, the adoption of implantable collamer lens is expected to gain traction at a considerable pace.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors are Restraining the Demand for Implantable Collamer Lens?

ICL is regarded as a cosmetic procedure, similar to LASIK, and is most likely not covered under insurance coverage. Due to the personalised nature of implants, an ICL is often more expensive per eye than LASIK.

Despite the fact that ICLs are designed to last indefinitely, it is still advised to schedule routine follow-up appointments to make sure the implants are in place and to check for premature cataracts, which could necessitate cataract surgery and raise intraocular pressure. These factors might limit the adoption of ICLs.

Country-wise Insights

What Makes the China Implantable Collamer Lens Market Lucrative?

“Rising Demand for Implantable Contact Lens in China Will Boost Sales”

China dominated the East Asia implantable collamer lens market, accounting for around 46.6% of the total market share in 2021. As per FMI, the trend is expected to continue over the forecast period.

With the approval of STAR SURGICAL’s Visian Implantable Collamer Lens with CentraFLOW technology in China in 2014, the country is witnessing advancements in the field of optical products, which is expected to augment the growth in the market.

What Makes the U.K. Implantable Collamer Lens Market Attractive?

“High Influx of Medical Tourists in the U.K. Will Fuel Sales of Implantable Collamer Lens”

Europe accounted for nearly 26.1% of the global implantable collamer lens market in 2021, with the U.K. emerging as a lucrative pocket. The first implants of the 2011 CE Mark-approved Visian® Implantable Collamer® Lens (ICL(TM)) by STAR SURGICAL were performed in the Europe.

Before the product's complete market debut in the nations that receive CE Mark approvals, these were the initial steps in the company's pre-launch plan for the product at eight sites and 100 eyes.

What is the Japan Implantable Collamer Lens Market Outlook?

“Increasing Adoption of Collamer Lens Surgery in Japan Will Spur Growth”

The Japan implantable collamer lens market held around 17.8% of the global market share in 2021. In Japan, ICL clinical studies began in 2003 and were eventually approved by the Ministry of Health, Labor, and Welfare in 2010.

Prior to the development of Hole ICLs, postoperative complications from glaucoma and cataract surgery were an issue for early ICLs. However, these complications are no longer a problem because of Hole ICLs.

Only ten highly qualified instructors are now authorised to observe and licence the surgery of doctors who desire to operate an ICL in Japan. As a result, demand for implantable collamer lens in Japan is forecast to increase at a considerable pace.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Indication of Implantable Collamer Lens is Largely in Focus?

“Demand for Implantable Collamer Lens for Myopia Will Remain High”

Based on indication, the myopia segment accounted for 78.2% of the total market share in 2021. Sales in this segment are expected to grow at a 12.6% CAGR over the forecast period. High prevalence of myopic disorders have given way to addressing several indications related to refractive diseases which are highly prevalent globally. The myopic segment of indication is a prime driver for the f implantable collamer lenses market.

Which End User Benefits the Most With the Sales of Implantable Collamer Lens?

“Adoption of Implantable Collamer Lens in Hospital Settings is More Preferred”

In terms of end user, the hospitals segment held 52.4% of the total market share in 2021. Large number of procedures performed with reference to implantable ocular surgeries are undertaken within hospital settings. Prime driver for the same includes the availability of surgical equipment, implants, and the progression of the surgical procedure in the presence of skilled professions.

Competitive Landscape

STAR SURGICAL dominates the market for implantable collamer lenses. Only one posterior chamber phakic IOL (PIOL) has been given FDA marketing and sales approval in the U.S., and that is the implantable collamer lens manufactured by STAAR SURGICAL.

  • In March 2022, STAAR Surgical announced the U.S. FDA approval of EVO Visian® Implantable Collamer® Lenses.
  • In April 2022, STAAR Surgical announced first implants of EVO Visian ICL in the U.S.
  • In June 2022, STAAR Surgical celebrated two million lens milestone for Implantable Collamer® Lens (ICL).

Report Scope as per Implantable Collamer Lens Industry Analysis

Attribute

Details

Estimated Market Size (2022)

US$ 244.8 Mn

Projected Market Valuation (2032)

US$ 838.2 Mn

Value-based CAGR (2022-2032)

13.1%

Forecast Period

2017-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA

Key Market Segments Covered

Indication, End User, and Region

Key Company Profiled

STAAR SURGICAL

Pricing

Available upon Request

Key Market Segments Covered in Implantable Collamer Lens Industry Research

By Indication:

  • Myopia
  • Hyperopia
  • Astigmatism

By End User:

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
  • Eye Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Frequently Asked Questions

The global implantable collamer lens market is worth US$ 212.9 Mn in 2021, and is set to expand 3.4X over the next ten years.

The implantable collamer lens market is expected to reach US$ 838.2 Mn by the end of 2032, with sales revenue expected to register 13.1% CAGR.

Growing burden of ocular diseases, rising ageing population, and regulatory approvals of various ophthalmic products, are some of the key trends in this market.

China is the top region which is expected to drive demand for the implantable collamer lens industry.

The U.S. is one of the key markets for implantable collamer lens accounting for about 4.4% of the global implantable collamer lens market in the year 2021.

Demand for implantable collamer lens in Europe is expected to register a growth of 16.2% over the next ten years.

China, Europe, and Japan are the key producers of implantable collamer lens.

STAAR SURGICAL is the key player in the implantable collamer lens industry.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions & Exclusions

3. Key Market Trends

    3.1. Demand Side Trends

    3.2. Supply Side Trends

4. Key Success Factors

    4.1. Disease Epidemiology, by Region

    4.2. Product and Technology Assessment

    4.3. Regulatory Landscape

    4.4. Reimbursement Scenario

    4.5. Rise in Demand for Implantable Collamer Lenses

    4.6. PESTEL Analysis

    4.7. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Rising Geriatric Population

        5.2.3. Adoption of LASIK Procedures

        5.2.4. Growing Volumes of Refractive Surgery

        5.2.5. Cost of Lens Implantation

        5.2.6. High Prevalence of Diabetic Population Group

        5.2.7. Global Epidemiology of Cataract

        5.2.8. Rising Government Support to Control and Treat Blindness

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. Current COVID-19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 Economic analysis

    6.4. COVID-19 and Impact Analysis

        6.4.1. By Indication

        6.4.2. By End User

    6.5. 2021 Market Scenario

7. Global Implantable Collamer Lens Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by Indication

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Indication Type, 2017–2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032

        8.3.1. Myopia

        8.3.2. Hyperopia

        8.3.3. Astigmatism

    8.4. Market Attractiveness Analysis By Indication

9. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by End User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

        9.3.1. Hospitals

        9.3.2. Ophthalmic Clinics

        9.3.3. Ambulatory Surgical Centers

        9.3.4. Eye Research Institutes

    9.4. Market Attractiveness Analysis By End User

10. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        10.3.1. US

        10.3.2. Europe

        10.3.3. China

        10.3.4. Japan

        10.3.5. ROW

    10.4. Market Attractiveness Analysis By Region

11. U.S. Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        11.3.1. By Indication

        11.3.2. By End User

    11.4. Market Attractiveness Analysis

    11.5. Key Market Participants - Intensity Mapping

    11.6. Drivers and Restraints - Impact Analysis

12. China Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        12.3.1. By Indication

        12.3.2. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Europe Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Indication

        13.3.2. By End User

    13.4. Market Attractiveness Analysis

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

14. Japan Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        14.3.1. By Indication

        14.3.2. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Rest of the World Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        15.3.1. By Indication

        15.3.2. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

        16.4.1. By Regional footprint of Players

        16.4.2. Indication footprint of Players

        16.4.3. Chanel footprint of Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. STAAR SURGICAL

            17.3.1.1. Overview

            17.3.1.2. Indication Portfolio

            17.3.1.3. Key Financials

            17.3.1.4. SWOT Analysis

            17.3.1.5. Sales Footprint

            17.3.1.6. Analyst Commentary

            17.3.1.7. Strategy Overview

                17.3.1.7.1. Marketing Strategy

                17.3.1.7.2. Indication Strategy

                17.3.1.7.3. Channel Strategy

18. Assumptions and Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication

Table 02: Global Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022-2032, By End User

Table 03: Global Implantable Collamer Lens Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Region

Table 04: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 05: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication

Table 06: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 07: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 08: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication

Table 09: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 10: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 11: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication

Table 12: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 13: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 14: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication

Table 15: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 16: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 17: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication

Table 18: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Implantable Collamer Lens Market, By Indication, 2022E

Figure 02: Global Implantable Collamer Lens Market, By End User, 2022E

Figure 03: Global Implantable Collamer Lens Market, By Region, 2022E

Figure 04: Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021

Figure 05: Global Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), Analysis, 2022-2032

Figure 06: Global Implantable Collamer Lens Market Absolute $ Opportunity Analysis, 2022-2032

Figure 07: Global Implantable Collamer Lens Market Analysis by Indication–2022 & 2032

Figure 08: Global Implantable Collamer Lens Market Y-o-Y Growth Projections by Indication, 2022-2032

Figure 09: Global Implantable Collamer Lens Market Attractiveness Analysis, By Indication

Figure 10: Global Implantable Collamer Lens Market Analysis by End User–2022 & 2032

Figure 11: Global Implantable Collamer Lens Market Y-o-Y Growth (%) By End User, 2022-2032

Figure 12: Global Implantable Collamer Lens Market Attractiveness Analysis, By End User

Figure 13: Global Implantable Collamer Lens Market Share Analysis (%) by Region, 2022 & 2032

Figure 14: Global Implantable Collamer Lens Market Y-o-Y Growth (%) by Region, 2022–2032

Figure 15: Global Implantable Collamer Lens Market Attractiveness Analysis, By Region

Figure 16: U.S. Implantable Collamer Lens Market Value Share, By Country (2022F)

Figure 17: U.S. Implantable Collamer Lens Market Value Share, By Indication (2022E)

Figure 18: U.S. Implantable Collamer Lens Market Value Share, By End User (2022E)

Figure 19: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021

Figure 20: U.S. Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032

Figure 21: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By Indication

Figure 22: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By End User

Figure 23: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By Country

Figure 24: China Implantable Collamer Lens Market Value Share, By Country (2022F)

Figure 25: China Implantable Collamer Lens Market Value Share, By Indication (2022E)

Figure 26: China Implantable Collamer Lens Market Value Share, By End User (2022E)

Figure 27: China Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021

Figure 28: China Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032

Figure 29: China Implantable Collamer Lens Market Attractiveness Analysis, By Indication

Figure 30: China Implantable Collamer Lens Market Attractiveness Analysis, By End User

Figure 31: China Implantable Collamer Lens Market Attractiveness Analysis, By Country

Figure 32: Europe Implantable Collamer Lens Market Value Share, By Country (2022F)

Figure 33: Europe Implantable Collamer Lens Market Value Share, By Indication (2022E)

Figure 34: Europe Implantable Collamer Lens Market Value Share, By End User (2022E)

Figure 35: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021

Figure 36: Europe Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032

Figure 37: Europe Implantable Collamer Lens Market Attractiveness Analysis, By Indication

Figure 38: Europe Implantable Collamer Lens Market Attractiveness Analysis, By End User

Figure 39: Europe Implantable Collamer Lens Market Attractiveness Analysis, By Country

Figure 40: Japan Implantable Collamer Lens Market Value Share, By Country (2022F)

Figure 41: Japan Implantable Collamer Lens Market Value Share, By Indication (2022E)

Figure 42: Japan Implantable Collamer Lens Market Value Share, By End User (2022E)

Figure 43: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021

Figure 44: Japan Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032

Figure 45: Japan Implantable Collamer Lens Market Attractiveness Analysis, By Indication

Figure 46: Japan Implantable Collamer Lens Market Attractiveness Analysis, By End User

Figure 47: Japan Implantable Collamer Lens Market Attractiveness Analysis, By Country

Figure 48: Rest of the World Implantable Collamer Lens Market Value Share, By Country (2022E)

Figure 49: Rest of the World Implantable Collamer Lens Market Value Share, By Indications (2022E)

Figure 50: Rest of the World Implantable Collamer Lens Market Value Share, By End User (2022E)

Figure 51: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021

Figure 52: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032

Figure 53: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By Indication

Figure 54: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By End User

Figure 55: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By Country

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Implantable Infusion Pump Market

Published : July 2017

Healthcare

Subcutaneous Implantable Defibrillator Market

Published : December 2016

Healthcare

Subcutaneous Implantable Defibrillator System Market

Published : January 1970

Google translate

Implantable Collamer Lens Market